经皮治疗含结石的肾盏憩室:相关因素与结局
回顾性分析51例肾盏憩室结石患者经皮肾镜取石术的结局,并与571例无憩室肾结石患者比较。憩室组更年轻、体重指数更低、女性更多,82%憩室结石含磷酸钙,所有憩室患者至少存在1项代谢异常。经皮治疗成功率为96%,并发症率为4%。
要点
- 经皮治疗肾盏憩室结石成功率为96%,并发症率为4%。
- 憩室结石82%含磷酸钙,而无憩室肾结石患者仅33%含磷酸钙。
- 所有肾盏憩室患者均存在至少1项代谢异常。
核心结论
- 经皮治疗肾盏憩室安全有效,不受憩室大小或位置(包括前壁憩室)影响。
- 漏斗部颈部扩张似乎并非必要。
- 相当比例的肾盏憩室患者存在代谢异常。
研究设计与样本
- 回顾性识别51例肾盏憩室患者,来自前瞻性维护的经皮肾镜取石术数据库。
- 完整数据患者分为14例结石仅位于憩室内和15例憩室内外均有肾结石。
- 以571例无憩室的肾结石患者作为对照。
- 采用卡方检验和t检验评估统计学差异。
主要发现
- 与无憩室肾结石患者相比,结石仅位于憩室内的患者更年轻(44岁 vs 54岁,p=0.024),体重指数更低(23.2 vs 27 kg/m²,p=0.032),女性比例更高(71% vs 44%,p=0.046)。
- 29例中19例憩室位于前壁,15例位于上极。
- 憩室平均大小2.5 cm,结石负荷1.5 cm。
- 经皮治疗成功率为96%,并发症率为4%,51例中22例(43%)行憩室颈部扩张。
- 51例患者5年随访期间1例结石复发,经输尿管镜处理,46例憩室完全消失,5例憩室缩小。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We evaluated the outcomes of percutaneous treatment and metabolic evaluation of calyceal diverticula with associated stones. MATERIALS AND METHODS: We retrospectively identified 51 patients with a calyceal diverticulum in our prospectively maintained percutaneous nephrolithotomy database. Patients with complete data were separated into 14 with stones isolated to the diverticulum and 15 with renal stones in and outside the diverticulum. A total of 571 patients with renal stones but no diverticulum were used for comparison. Statistical differences were assessed using the chi-square test and the t-test. RESULTS: Patients with stones isolated to the diverticulum were younger (44 vs 54 years, p = 0.024), had a lower body mass index (23.2 vs 27 kg/m2, p = 0.032) and were more often female (71% vs 44%, p = 0.046) compared to patients with renal stones but no diverticulum. Calyceal diverticula were anterior in 19 of 29 cases and in the upper pole in 15. Average diverticular size was 2.5 cm with a 1.5 cm stone burden. Percutaneous treatment was successful in 96% of patients with a 4% complication rate. The diverticular neck was dilated in 22 of 51 patients (43%). During 5-year followup in the 51 patients there was 1 stone recurrence, which was managed by ureteroscopy, while 46 and 5 patients showed complete absence and reduction of the diverticulum, respectively. Of the calyceal diverticular stones 82% contained calcium phosphate compared to only 33% in patients with renal stones but no diverticulum. All patients with a diverticulum had at least 1 metabolic derangement. CONCLUSIONS: Percutaneous treatment of calyceal diverticula is safe and effective regardless of size or location, including anterior diverticula. Infundibular neck dilation does not appear to be necessary. There are metabolic abnormalities in a significant proportion of patients with a calyceal diverticulum.
引用
- Parkhomenko E, Tran T, Thai J, et al. Percutaneous Management of Stone Containing Calyceal Diverticula: Associated Factors and Outcomes. J Urol. 2017. PMID: 28483573. doi:10.1016/j.juro.2017.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。